Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Renaissance Insurance reported for 3 months of 2025 by RAS

4/17/25 RENI

Rosgosstrakh reported for 3 months of 2025 by RAS

4/17/25 RGSS

Inter RAO started the main stage of construction of the Novolenskaya TPP

4/17/25 IRAO

Shareholders of Yandex approved dividends for 2024

4/17/25 YDEX

X5 opened laboratories for testing innovative technologies

4/17/25 X5

Ozone Pharmaceuticals reported for 2024 by RAS

4/17/25 OZPH

Alrosa may engage in gold mining in Chukotka

4/17/25 ALRS

Delimobile in Q1 increased revenue from b2b-carsharing by 44%

4/17/25 DELI

MMK's sales in Q1 decreased by 11%

4/17/25 MAGN

Vyborg Shipyard reported for 3 months of 2025 by RAS

4/17/25 VSYD